Research Summary
Recombinant human follicle-stimulating hormone (rhFSH) is a hormone produced through recombinant DNA technology, typically used in ovarian stimulation treatments during assisted reproductive technologies, such as in vitro fertilization (IVF). Follicle-stimulating hormone is a protein hormone secreted by the pituitary gland that primarily stimulates the development and maturation of ovarian follicles in females. Traditionally, follicle-stimulating hormone was extracted from urine, but recombinant technology allows for the production of pure rhFSH in the laboratory, eliminating impurities that may occur in the urine extraction process. rhFSH is clinically used to treat infertility, ovarian dysfunction, and other conditions, helping women produce multiple mature follicles and increasing the chances of pregnancy. It is also used in male treatments, particularly for low testosterone levels caused by pituitary or hypothalamic issues, to stimulate sperm production.
According to WENKH research statistics, the global Recombinant Human Follicle-stimulating Hormone market size will reach 1,337.95 Million USD in 2026 and is projected to reach 1,991.94 Million USD by 2033, with a CAGR of 5.85% (2026-2033). Among them, the Asia-Pacific Recombinant Human Follicle-stimulating Hormone market is undergoing rapid changes, reaching Million USD in 2026, accounting for approximately % of the global market share. It is projected to reach Million USD by 2033.
The global Recombinant Human Follicle-stimulating Hormone market is highly competitive, with key market players including Merck, Ferring, Livzon, Gedeon Richter, GenSci, Teva, ChangChun High & New Technology, ABL, Scripps Laboratories, Alphamab Oncology, Hunan Jingfeng Pharmaceutical, Qilu Pharmaceutical, Beijing SL Pharmaceutical, etc. This report categorizes the competitive landscape of the global Recombinant Human Follicle-stimulating Hormone market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Recombinant Human Follicle-stimulating Hormone market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Recombinant Human Follicle-stimulating Hormone industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Recombinant Human Follicle-stimulating Hormone and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2021 to 2025, providing a solid foundation for analyzing past market trends. The year 2026 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2027 to 2033, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers countries including United States, China, Germany, Japan, France, South Korea, United Kingdom, India, Italy, Brazil, Mexico, Indonesia, Vietnam and South Africa. It particularly focuses on the sales revenue of Recombinant Human Follicle-stimulating Hormone in these countries, as well as the product segmentation and downstream application market size of each country. The report provides an in-depth analysis of the regional distribution and future development trends of the Recombinant Human Follicle-stimulating Hormone market. By considering local policies, this report evaluates the market prospects of Recombinant Human Follicle-stimulating Hormone in each country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Merck
Ferring
Livzon
Gedeon Richter
GenSci
Teva
ChangChun High & New Technology
ABL
Scripps Laboratories
Alphamab Oncology
Hunan Jingfeng Pharmaceutical
Qilu Pharmaceutical
Beijing SL Pharmaceutical
Product Segment
75IU
150IU
Others
Product Application
Infertility Treatment
Assisted Reproductive Technology
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Recombinant Human Follicle-stimulating Hormone Industry Chain Analysis
Chapter 3: Global Recombinant Human Follicle-stimulating Hormone Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Recombinant Human Follicle-stimulating Hormone Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Specifications and Features, Product Revenue and Product Gross Profit Margin)
Chapter 6: Global Recombinant Human Follicle-stimulating Hormone Market Analysis by Countries, Product Segment and Downstream Application
Chapter 7: United States Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 8: China Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 9: Germany Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 10: Japan Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 11: France Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 12: South Korea Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 13: United Kingdom Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 14: India Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 15: Italy Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 16: Brazil Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 17: Mexico Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 18: Indonesia Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 19: Vietnam Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 20: South Africa Recombinant Human Follicle-stimulating Hormone Market Size, Product Segment, Downstream Application Analysis
Chapter 21: Research Conclusion
Chapter 22: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Content
1 Recombinant Human Follicle-stimulating Hormone Market Overview
1.1 Product Definition Introduction
1.2 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis (2021-2033)
1.3 Recombinant Human Follicle-stimulating Hormone Market Status and Development Prospects
1.3.1 Recombinant Human Follicle-stimulating Hormone Market Status
1.3.2 Recombinant Human Follicle-stimulating Hormone Industry Development Prospects
1.4 Recombinant Human Follicle-stimulating Hormone Market Overview by Product Segment
1.4.1 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Segment: 2021 VS 2026 VS 2033
1.4.2 75IU
1.4.3 150IU
1.4.4 Others
1.5 Recombinant Human Follicle-stimulating Hormone Market Overview by Product Application
1.5.1 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Application: 2021 VS 2026 VS 2033
1.5.2 Infertility Treatment
1.5.3 Assisted Reproductive Technology
2 Recombinant Human Follicle-stimulating Hormone Industry Supply Chain Analysis
2.1 Recombinant Human Follicle-stimulating Hormone Supply Chain
2.2 Recombinant Human Follicle-stimulating Hormone Midstream Suppliers
2.3 Recombinant Human Follicle-stimulating Hormone Downstream Customers
2.4 Recombinant Human Follicle-stimulating Hormone Sales Channel Analysis
3 Recombinant Human Follicle-stimulating Hormone Market Environment Analysis
3.1 Recombinant Human Follicle-stimulating Hormone Industry Policy Analysis
3.2 Recombinant Human Follicle-stimulating Hormone Emerging Technology Trends in the Industry
3.3 Recombinant Human Follicle-stimulating Hormone Restraining Factors Analysis
3.4 Recombinant Human Follicle-stimulating Hormone Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Recombinant Human Follicle-stimulating Hormone Market Players Competition Landscape
4.1 Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Key Players (2021-2026)
4.2 Global Recombinant Human Follicle-stimulating Hormone Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Recombinant Human Follicle-stimulating Hormone Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Merck
5.1.1 Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Merck Recombinant Human Follicle-stimulating Hormone Product Features
5.1.3 Merck Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.2 Ferring
5.2.1 Ferring Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 Ferring Recombinant Human Follicle-stimulating Hormone Product Features
5.2.3 Ferring Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.3 Livzon
5.3.1 Livzon Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 Livzon Recombinant Human Follicle-stimulating Hormone Product Features
5.3.3 Livzon Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.4 Gedeon Richter
5.4.1 Gedeon Richter Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Features
5.4.3 Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.5 GenSci
5.5.1 GenSci Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 GenSci Recombinant Human Follicle-stimulating Hormone Product Features
5.5.3 GenSci Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.6 Teva
5.6.1 Teva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Teva Recombinant Human Follicle-stimulating Hormone Product Features
5.6.3 Teva Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.7 ChangChun High & New Technology
5.7.1 ChangChun High & New Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Features
5.7.3 ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.8 ABL
5.8.1 ABL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 ABL Recombinant Human Follicle-stimulating Hormone Product Features
5.8.3 ABL Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.9 Scripps Laboratories
5.9.1 Scripps Laboratories Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Features
5.9.3 Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.10 Alphamab Oncology
5.10.1 Alphamab Oncology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Features
5.10.3 Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.11 Hunan Jingfeng Pharmaceutical
5.11.1 Hunan Jingfeng Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
5.11.3 Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.12 Qilu Pharmaceutical
5.12.1 Qilu Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.12.2 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
5.12.3 Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
5.13 Beijing SL Pharmaceutical
5.13.1 Beijing SL Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.13.2 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
5.13.3 Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Revenue and Gross Margin Analysis (2021-2026)
6 Global Recombinant Human Follicle-stimulating Hormone Market Analysis by Countries, by Product Segment and Application
6.1 Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast by Countries: 2021 VS 2026 VS 2033
6.1.1 Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Countries (2021-2026)
6.1.2 Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Countries (2027-2033)
6.2 Global Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
6.3 Global Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
7 United States Recombinant Human Follicle-stimulating Hormone Market Analysis
7.1 United States Recombinant Human Follicle-stimulating Hormone Market Prospects
7.2 United States Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
7.3 United States Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
8 China Recombinant Human Follicle-stimulating Hormone Market Analysis
8.1 China Recombinant Human Follicle-stimulating Hormone Market Prospects
8.2 China Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
8.3 China Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
9 Germany Recombinant Human Follicle-stimulating Hormone Market Analysis
9.1 Germany Recombinant Human Follicle-stimulating Hormone Market Prospects
9.2 Germany Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
9.3 Germany Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
10 Japan Recombinant Human Follicle-stimulating Hormone Market Analysis
10.1 Japan Recombinant Human Follicle-stimulating Hormone Market Prospects
10.2 Japan Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
10.3 Japan Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
11 France Recombinant Human Follicle-stimulating Hormone Market Analysis
11.1 France Recombinant Human Follicle-stimulating Hormone Market Prospects
11.2 France Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
11.3 France Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
12 South Korea Recombinant Human Follicle-stimulating Hormone Market Analysis
12.1 South Korea Recombinant Human Follicle-stimulating Hormone Market Prospects
12.2 South Korea Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
12.3 South Korea Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
13 United Kingdom Recombinant Human Follicle-stimulating Hormone Market Analysis
13.1 United Kingdom Recombinant Human Follicle-stimulating Hormone Market Prospects
13.2 United Kingdom Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
13.3 United Kingdom Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
14 India Recombinant Human Follicle-stimulating Hormone Market Analysis
14.1 India Recombinant Human Follicle-stimulating Hormone Market Prospects
14.2 India Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
14.3 India Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
15 Italy Recombinant Human Follicle-stimulating Hormone Market Analysis
15.1 Italy Recombinant Human Follicle-stimulating Hormone Market Prospects
15.2 Italy Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
15.3 Italy Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
16 Brazil Recombinant Human Follicle-stimulating Hormone Market Analysis
16.1 Brazil Recombinant Human Follicle-stimulating Hormone Market Prospects
16.2 Brazil Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
16.3 Brazil Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
17 Mexico Recombinant Human Follicle-stimulating Hormone Market Analysis
17.1 Mexico Recombinant Human Follicle-stimulating Hormone Market Prospects
17.2 Mexico Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
17.3 Mexico Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
18 Indonesia Recombinant Human Follicle-stimulating Hormone Market Analysis
18.1 Indonesia Recombinant Human Follicle-stimulating Hormone Market Prospects
18.2 Indonesia Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
18.3 Indonesia Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
19 Vietnam Recombinant Human Follicle-stimulating Hormone Market Analysis
19.1 Vietnam Recombinant Human Follicle-stimulating Hormone Market Prospects
19.2 Vietnam Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
19.3 Vietnam Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
20 South Africa Recombinant Human Follicle-stimulating Hormone Market Analysis
20.1 South Africa Recombinant Human Follicle-stimulating Hormone Market Prospects
20.2 South Africa Recombinant Human Follicle-stimulating Hormone Market Size by Product Segment (2021-2033)
20.3 South Africa Recombinant Human Follicle-stimulating Hormone Market Size by Product Application (2021-2033)
21 Research Conclusion
22 Appendix
22.1 Methodology/Research Approach
22.2 Research Landscape
22.3 Research Benchmark and Hypothesis
22.4 Data Source
22.4.1 Primary Sources
22.4.2 Secondary Sources
22.5 Data Cross Validation
22.6 Disclaimer
Table 1：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Segment (2021 VS 2026 VS 2033) & (Million USD)
Table 2：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis by Product Application (2021 VS 2026 VS 2033) & (Million USD)
Table 3：Recombinant Human Follicle-stimulating Hormone Downstream Customers List
Table 4：Recombinant Human Follicle-stimulating Hormone Distributors/Dealers List
Table 5：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Key Players (2021-2026) & (Million USD)
Table 6：Global Recombinant Human Follicle-stimulating Hormone Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Recombinant Human Follicle-stimulating Hormone Market Expansion and M&A Dynamic
Table 9：Merck Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Merck Recombinant Human Follicle-stimulating Hormone Product Features
Table 11：Merck Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 12：Ferring Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 13：Ferring Recombinant Human Follicle-stimulating Hormone Product Features
Table 14：Ferring Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 15：Livzon Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 16：Livzon Recombinant Human Follicle-stimulating Hormone Product Features
Table 17：Livzon Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 18：Gedeon Richter Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 19：Gedeon Richter Recombinant Human Follicle-stimulating Hormone Product Features
Table 20：Gedeon Richter Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 21：GenSci Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 22：GenSci Recombinant Human Follicle-stimulating Hormone Product Features
Table 23：GenSci Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 24：Teva Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Teva Recombinant Human Follicle-stimulating Hormone Product Features
Table 26：Teva Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 27：ChangChun High & New Technology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 28：ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Product Features
Table 29：ChangChun High & New Technology Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 30：ABL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 31：ABL Recombinant Human Follicle-stimulating Hormone Product Features
Table 32：ABL Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 33：Scripps Laboratories Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 34：Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Product Features
Table 35：Scripps Laboratories Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 36：Alphamab Oncology Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 37：Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Product Features
Table 38：Alphamab Oncology Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 39：Hunan Jingfeng Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
Table 41：Hunan Jingfeng Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 42：Qilu Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 43：Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
Table 44：Qilu Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 45：Beijing SL Pharmaceutical Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 46：Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Product Features
Table 47：Beijing SL Pharmaceutical Recombinant Human Follicle-stimulating Hormone Revenue (Million USD) and Gross Margin (2021-2026)
Table 48：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast by Countries (2021 VS 2026 VS 2033) & (Million USD)
Table 49：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Countries (2021-2026) & (Million USD)
Table 50：Global Recombinant Human Follicle-stimulating Hormone Market Share by Countries (2021-2026)
Table 51：Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 52：Global Recombinant Human Follicle-stimulating Hormone Market Share Forecast by Countries (2027-2033)
Table 53：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 54：Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 55：Global Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 56：Global Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 57：United States Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 58：United States Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 59：United States Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 60：United States Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 61：China Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 62：China Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 63：China Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 64：China Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 65：Germany Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 66：Germany Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 67：Germany Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 68：Germany Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 69：Japan Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 70：Japan Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 71：Japan Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 72：Japan Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 73：France Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 74：France Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 75：France Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 76：France Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 77：South Korea Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 78：South Korea Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 79：South Korea Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 80：South Korea Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 81：United Kingdom Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 82：United Kingdom Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 83：United Kingdom Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 84：United Kingdom Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 85：India Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 86：India Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 87：India Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 88：India Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 89：Italy Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 90：Italy Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 91：Italy Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 92：Italy Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 93：Brazil Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 94：Brazil Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 95：Brazil Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 96：Brazil Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 97：Mexico Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 98：Mexico Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 99：Mexico Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 100：Mexico Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 101：Indonesia Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 102：Indonesia Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 103：Indonesia Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 104：Indonesia Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 105：Vietnam Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 106：Vietnam Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 107：Vietnam Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 108：Vietnam Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 109：South Africa Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 110：South Africa Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 111：South Africa Recombinant Human Follicle-stimulating Hormone Market Revenue by Product Application (2021-2026) & (Million USD)
Table 112：South Africa Recombinant Human Follicle-stimulating Hormone Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 113：Secondary Sources
Figure 1：Recombinant Human Follicle-stimulating Hormone Product Scope
Figure 2：Global Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast Analysis (2021-2033) & (Million USD)
Figure 3：Global Recombinant Human Follicle-stimulating Hormone Product Segment Market Share (2026 & 2033)
Figure 4：Global Recombinant Human Follicle-stimulating Hormone Product Application Market Share (2026 & 2033)
Figure 5：75IU Product Scope
Figure 6：150IU Product Scope
Figure 7：Others Product Scope
Figure 8：Infertility Treatment Product Scope
Figure 9：Assisted Reproductive Technology Product Scope
Figure 10：Recombinant Human Follicle-stimulating Hormone Industrial Chain Framework
Figure 11：Global Recombinant Human Follicle-stimulating Hormone Market by Geographic Segmentation in 2026
Figure 12：Global Recombinant Human Follicle-stimulating Hormone Market Share by Countries (2021 VS 2026)
Figure 13：United States Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 14：China Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 15：Germany Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 16：Japan Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 17：France Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 18：South Korea Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 19：United Kingdom Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 20：India Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 21：Italy Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 22：Brazil Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 23：Mexico Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 24：Indonesia Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 25：Vietnam Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 26：South Africa Recombinant Human Follicle-stimulating Hormone Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 27：Research Methodology
Figure 28：Primary Sources
Figure 29：Data Cross Validation
Global Recombinant Human Follicle-stimulating Hormone Revenue and Market Share by Key Players
| Revenue (US$ Million) | 2020 | 2021 | 2022 | 2023 | 2024 |
| Merck | XX | XX | XX | XX | XX |
| Ferring | XX | XX | XX | XX | XX |
| Livzon | XX | XX | XX | XX | XX |
| Gedeon Richter | XX | XX | XX | XX | XX |
| GenSci | XX | XX | XX | XX | XX |
| Teva | XX | XX | XX | XX | XX |
| ChangChun High & New Technology | XX | XX | XX | XX | XX |
| ABL | XX | XX | XX | XX | XX |
| Scripps Laboratories | XX | XX | XX | XX | XX |
| Alphamab Oncology | XX | XX | XX | XX | XX |
| Hunan Jingfeng Pharmaceutical | XX | XX | XX | XX | XX |
| Qilu Pharmaceutical | XX | XX | XX | XX | XX |
| Beijing SL Pharmaceutical | XX | XX | XX | XX | XX |
| Other Companies | XX | XX | XX | XX | XX |
| Total | XX | XX | XX | XX | XX |
English
Related Reports 
